However, in breast cancer, FUNDC1 likely functions as a tumor promoter through different mechanisms, in which depletion of FUNDC1 blocks TNBC cell proliferation by deregulating Ca2+ release from the ER and through NFATC1 activation, which are reversed by overexpression of BMI1 [210]. This evidence concerns the gene NFATC1 and breast carcinoma.